about
sameAs
Neurophysiological biomarkers for Lewy body dementiasMorphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS studyIrrelevant features of a stimulus can either facilitate or disrupt performance in a working memory task: the role of fluid intelligence.GABA content within the ventromedial prefrontal cortex is related to trait anxietyOne further case of pancytopenia induced by olanzapine in a Parkinson's disease patient.Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders.GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images.Age-related changes of evoked potentials.Temporal evolution of oscillatory activity predicts performance in a choice-reaction time reaching task.Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies.Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseFocusing narrowly or broadly attention when judging categorical and coordinate spatial relations: a MEG study.Modulation of gamma and theta spectral amplitude and phase synchronization is associated with the development of visuo-motor learning.Dopamine transporter single-photon emission computerized tomography supports diagnosis of akinetic crisis of parkinsonism and of neuroleptic malignant syndrome.Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance EvidencesCritical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism: Report of 3 Cases.Structural Connectivity is Differently Altered in Dementia with Lewy Body and Alzheimer's DiseaseA randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patientsMultimodal EEG-MRI in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies.Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.Giant early components of somatosensory evoked potentials to tibial nerve stimulation in cortical myoclonusStructural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study.Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies.fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodiesMPTP induced parkinsonian syndrome: long term follow-up and neurophysiological study.Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process.Akinetic crisis in dementia with Lewy bodies.Early-onset parkinsonism caused by alpha-synuclein gene triplication: Clinical and genetic findings in a novel family.Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study.Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.Amantadine in the treatment of pathological gambling: a case report.Peripheral cytokines profile in Parkinson's disease.Reversible parkinsonism induced by prolonged treatment with valproate.Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
P50
Q26800048-381446CB-AED7-473B-98A3-7DAEE2BDEB0AQ27314575-16D99C78-9036-4A52-9907-219F44F3A145Q30473638-FBA1EC3D-6E40-4030-84EA-C5D0C5642F3DQ31034674-B72A0D0E-7D27-433C-9A8C-C5293BE77DF3Q31814423-7949CBBD-58F0-4E69-8C13-5384DBD27D61Q33492026-EC3532A6-7147-4E10-B06C-F19A1298BA81Q33800742-93957E6B-BF8A-4D57-8441-571221372038Q33924428-53FC0D02-E994-4BBF-924B-3C1599576894Q34297211-CC7DDD39-8E88-49BB-A7B3-4144E5998DCAQ34502591-C7C5A153-3A6B-49F1-AF27-0F4F4B0EBA15Q34619534-62EF6546-AD93-4B59-8FF1-671DBA241E08Q34732390-35AB13B3-F371-48AA-94E1-A9DD62E92983Q34806122-A33166F1-F7E2-42E0-883E-B9929BD6E6DCQ35080358-65053CA8-C875-4A07-B01B-9C5E97A5B1ECQ35502222-8A1A4700-0960-4498-AF88-BDA33F911EBCQ36009114-8C6F22D7-9196-4043-B9B7-E57B7CA495B6Q36098778-E76730F6-36E8-48DC-A583-4311C230374FQ36196647-CD882854-B960-45A3-9C88-939F295C0F6FQ36238721-F3AA8671-1D06-4338-8418-63E6A9318D10Q36366224-75A54747-58AA-433B-9421-5FD35D9E2D16Q36899995-D69E93A0-E7DB-4A69-9960-35D387A14EB9Q36993516-2CCFC3FD-A1B5-45CB-864A-E37CC5B84DFEQ37020745-64BB96A9-7DFB-4C90-95D6-A954EA59D9CBQ37105716-775D070C-7467-4206-A2D3-5118CBAF902CQ37510349-422E33BD-4344-4566-B9CA-A1E938895EEDQ37677185-D89E6583-4C2C-4551-8B64-468000CCDF75Q37685697-3A81BCF3-DE77-4867-BF9A-0D5BC5AD9CD1Q37699179-9757E676-97F6-45B0-87DC-97C9813FDB09Q38021200-4B3359FD-A6CB-4A79-9F58-5D125BA42DFEQ38244310-91ED8C59-2938-4A68-BB66-AA7CDFF2EDF5Q40439779-13DBA23D-2DCA-4BA8-8C3B-4DD6C0795AF5Q40805941-96577E25-508D-466D-93D6-80F95265FA6FQ40833150-6AD4C9B9-1F3A-410E-AA9B-4D1326818DB6Q41032798-02CCABE7-8706-4D6D-8F65-EE960F78AC64Q41615567-A4F753EF-8E20-450D-9EA6-A70EA70CE6C6Q42113307-329C5A81-6560-4819-81E6-11E562E73347Q42439761-40144C08-0AF0-43E0-9853-2225B91CC2FEQ42537852-EE6BEF12-B366-4450-BF7B-5EF5FF6BE69AQ42646907-2CB2FFD6-081B-49E7-8ADE-5EA061A220C7Q42675021-76A53B98-A467-4C32-A98F-EF542959C97B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marco Onofrj
@ast
Marco Onofrj
@en
Marco Onofrj
@es
Marco Onofrj
@nl
type
label
Marco Onofrj
@ast
Marco Onofrj
@en
Marco Onofrj
@es
Marco Onofrj
@nl
altLabel
Onofrj M
@en
marco onofrj
@en
prefLabel
Marco Onofrj
@ast
Marco Onofrj
@en
Marco Onofrj
@es
Marco Onofrj
@nl
P1053
K-7710-2016
P106
P1153
7006653830
P21
P31
P4012
P496
0000-0002-0480-2495